Clinical Trial Update: Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rituximab plus cladribine for newly diagnosed non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Cladribine (cladribine)
• Rituximab (rituximab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lymphoma | Phase 2 | Status: COMPLETED